Though T790M gatekeeper mutations in EGFR and KRAS mutations define resistance in a majority of non-small cell lung carcinoma (NSCLC) and colorectal cancer patients respectively, these mutations contribute minimally to resistance in HNSCC patients6. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.